Trial Information

Summary: Hematopoietic Cell Transplantation

Vical Incorporated is currently conducting a phase 2 study to evaluate the safety, immunogenicity, and clinical benefit of a study vaccine in controlling CMV recurrent infection in recipients undergoing hematopoietic cell transplantation, and their respective donors.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

• Be 18 – 65 years of age
• Be an allele-matched related donor to be considered as a donor for this study
• Be CMV-seropositive and able to and willing to be followed for 1 year to be a recipient

You will not qualify as a donor if you:

• Are pregnant or breast-feeding
• Have evidence of immunodeficiency
• Have a history of recent immunization, prior CMV therapy, or administration of an experimental CMV vaccine

You will not qualify as a recipient if you:

• Have an autoimmune disease
• Are a poor risk patient
• Have a certain type of anemia

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:33 AM